Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) was first discovered in 1962, since then it has been recognized as a major causative agent of healthcare-associated infections. MRSA infections are usually divided into three groups: hospital- (HA), community- (CA) and livestock-associated (LA) MRSA. The incidence of LA-MRSA infections among livestock and companion animals is a great concern because these sources could potentially be reservoirs for zoonotic infections. In Ukraine, recent statistics indicated approximately 82 % of tested livestock were S. aureus positive with 53.8 % of resistance. In addition, the diversity of MRSA in Ukraine has not been investigated.
 Antibiotic resistance during treatment in both clinical practice and veterinary medicine remains a challenge and requires alternative solutions. Bacteriophage-based treatment represents a promising biocontrol strategy with proven effectiveness against MRSA. The purpose of our research was to evaluate the activity of two commercial phage preparations against a local collection of LA-MRSA host strains and to characterize and adapt individual phages isolated from these preparations with the desired goal of enhancing their efficacy.
 In our study, we tested two commercial phage preparations (Eliava BioProduction, Georgia) Staphylococcus Bacteriophage and Intesti Bacteriophage on local LA-MRSA isolates. In addition, we utilized two single phages we isolated from these preparations. Both commercial phage preparations showed variable activity against the tested isolates. Intesti Bacteriophage cocktail lysed 60 % of isolates, whereas the single phage isolated from it was found to be ineffective. Staphylococcus Bacteriophage preparation showed activity against 30 % of MRSA tested, while the isolated phage was active against 70 % of the tested isolates. For the first time in Ukraine, in this study we assessed host range of commercial phages on local circulating livestock-associated MRSA. Further host range analysis on an expanded collection of Ukrainian MRSA isolates as well as taxonomic and genomic characterization of the phages is planned.
Highlights
Methicillin-resistant Staphylococcus aureus (MRSA) was first discovered in 1962, since it has been recognized as a major causative agent of healthcare-associated infections
MRSA infections are usually divided into three groups: hospital- (HA), community- (CA) and livestockassociated (LA) MRSA
The incidence of LA-MRSA infections among livestock and companion animals is a great concern because these sources could potentially be reservoirs for zoonotic infections
Summary
Methicillin-resistant Staphylococcus aureus (MRSA) was first discovered in 1962, since it has been recognized as a major causative agent of healthcare-associated infections. В рамках даної роботи нами було досліджено спектр активності двох комерційних препаратів бактеріофагів (Бактеріофаг Стафілококовий та Інтесті Бактеріофаг виробництва Eliava BioProduction, Грузія) проти циркулюючих ізолятів MRSA, виділених від тварин, продуктів харчування тваринного походження, а також з навколишнього середовища. У подальшому планується дослідження препаратів на більшій колекції штамів, а також секвенування виділених чистих ліній бактеріофагів.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Scientific and Technical Bulletin оf State Scientific Research Control Institute of Veterinary Medical Products and Fodder Additives аnd Institute of Animal Biology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.